The latest Web site updates, as well as information on CDC’s HIV prevention science, programs, and policies:
CDC has just awarded $109 million to 32 state and local health departments that represent the 57 jurisdictions across the United States prioritized in the federal initiative Ending the HIV Epidemic: A Plan for America (EHE). These jurisdictions include 48 counties, Washington, D.C., and San Juan, Puerto Rico, which account for more than half of new HIV diagnoses in the United States and nearly two-thirds of new diagnoses among African American and Hispanic/Latino communities, and seven states with a substantial rural burden of HIV.
In the United States (US) and dependent areas,a HIV diagnosesb are not evenly distributed across states and regions. Overall, in the 50 states and the District of Columbia only, most people who receive an HIV diagnosis live in urban areas.
CDC has recommended routine opt-out human immunodeficiency virus (HIV) testing since 2006, but the percentage of ambulatory care visits at which an HIV test is performed has remained low.
There are more than 160,000 people with undiagnosed HIV in the United States. The COVID-19 epidemic has made it more difficult to access traditional places where testing is provided, such as clinic-based testing sites, community-based organizations, and healthcare settings. Yet, the benefits of knowing one’s HIV status continue, including improved health and prevention. The Centers for Disease Control and Prevention (CDC) encourages people at risk for HIV infection to get tested in ways that are in compliance with stay-at-home orders and social distancing practices, including self-testing.
There are two kinds of HIV self-tests (Home Testing): 1) A Rapid Self-Test is done entirely at home or in a private location and can produce results within 20 minutes, and 2) A Mail-In Self-Test includes a specimen collection kit that contains supplies to collect dried blood from a fingerstick at home.
MMP is a cross-sectional, nationally representative, complex sample survey that assesses the behavioral and clinical characteristics of adults with diagnosed HIV infection in the United States. MMP also provides information on behaviors and clinical outcomes affecting risk of HIV transmission, morbidity, and mortality that are critical for achieving the goals of the Ending the HIV Epidemic: A Plan for America initiative, which seeks to reduce new HIV infections in the United States by 90% by 2030.
CDC collects data to monitor progress toward achieving national goals and the objectives set forth in other federal directives, including the updated strategic plan of the Division of HIV/AIDS Prevention. This surveillance supplemental report complements the 2018 HIV Surveillance Report and presents the results of focused analyses of National HIV Surveillance System data to measure progress toward achieving national goals.
This slide presents selected national HIV prevention and care outcomes used to gauge progress towards national HIV prevention and care goals and direct resources, monitor steps required from the time a person receives an HIV diagnosis to achieving viral suppression using data from the National HIV Surveillance System, and Monitor persons classified as having been prescribed PrEP relative to the estimated number of persons with indications for PrEP coverage.
.png)
No hay comentarios:
Publicar un comentario